Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma
Clinical trial NCT07205731 · RECRUITING
Trial details
- NCT number
- NCT07205731
- Sponsor
- University Hospital, Clermont-Ferrand
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-07
- Primary completion
- 2029-10-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.